BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1763794)

  • 21. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases].
    Wang XF; Jiang SC; Wei YL
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):482-4, 511. PubMed ID: 2086018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
    Fernandez LA
    J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug resistant shigellosis in south India.
    Paniker CK; Vimala KN; Bhat P; Stephen S
    Indian J Med Res; 1978 Sep; 68():413-7. PubMed ID: 744630
    [No Abstract]   [Full Text] [Related]  

  • 25. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nalidixic acid in resistant shigella infection.
    Agrawal ML; Mukherjee SP; Prasad SS
    J Assoc Physicians India; 1987 May; 35(5):390. PubMed ID: 3693298
    [No Abstract]   [Full Text] [Related]  

  • 27. International note. Antibiotics in the management of shigellosis.
    Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
    [No Abstract]   [Full Text] [Related]  

  • 28. Shigellosis in Calcutta during 1990-1992: antibiotic susceptibility pattern and clinical features.
    Bhattacharya MK; Bhattacharya SK; Paul M; Dutta D; Dutta P; Kole H; De D; Ghosh AR; Das P; Nair GB
    J Diarrhoeal Dis Res; 1994 Jun; 12(2):121-4. PubMed ID: 7963341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.
    Vinh H; Anh VT; Anh ND; Campbell JI; Hoang NV; Nga TV; Nhu NT; Minh PV; Thuy CT; Duy PT; Phuong le T; Loan HT; Chinh MT; Thao NT; Tham NT; Mong BL; Bay PV; Day JN; Dolecek C; Lan NP; Diep TS; Farrar JJ; Chau NV; Wolbers M; Baker S
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1264. PubMed ID: 21829747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nalidixic-acid-resistant Shigella dysenteriae I.
    Panhotra BR; Desai B; Sharma PL
    Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
    [No Abstract]   [Full Text] [Related]  

  • 31. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
    Mahmood A
    J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
    Moolasart P; Eampokalap B; Ratanasrithong M
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):764-9. PubMed ID: 10928373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.
    Anh NT; Cam PD; Dalsgaard A
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):856-62. PubMed ID: 12041563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics and clinical studies of norfloxacin in the pediatric field].
    Motohiro T; Yoshinaga Y; Tsumura N; Oki S; Sasaki H; Aramaki M; Oda K; Kawakami A; Koga T; Shimada Y
    Jpn J Antibiot; 1990 May; 43(5):901-17. PubMed ID: 2202843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shigella isolation in Vellore, south India (1997-2001).
    Jesudason MV
    Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 40. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.
    Wiström J; Jertborn M; Ekwall E; Norlin K; Söderquist B; Strömberg A; Lundholm R; Hogevik H; Lagergren L; Englund G
    Ann Intern Med; 1992 Aug; 117(3):202-8. PubMed ID: 1616214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.